The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
595055821 5950558 21 F 200310 20160714 20051223 20160715 EXP US-ROCHE-428465 ROCHE 18.11 YR F Y 147.00000 KG 20160715 LW US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
595055821 5950558 1 PS ACCUTANE ISOTRETINOIN 1 Oral Y 18662 40 MG BID
595055821 5950558 2 C TYLENOL ACETAMINOPHEN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
595055821 5950558 1 Acne cystic
595055821 5950558 2 Headache

Outcome of event

Event ID CASEID OUTC COD
595055821 5950558 OT
595055821 5950558 HO
595055821 5950558 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
595055821 5950558 Arthritis
595055821 5950558 Back pain
595055821 5950558 Colitis
595055821 5950558 Colitis ulcerative
595055821 5950558 Crohn's disease
595055821 5950558 Decreased appetite
595055821 5950558 Dehydration
595055821 5950558 Depression
595055821 5950558 Dermatitis atopic
595055821 5950558 Duodenal ulcer
595055821 5950558 Dyspepsia
595055821 5950558 Dysphagia
595055821 5950558 Eczema nummular
595055821 5950558 Gastric ulcer
595055821 5950558 Gastritis
595055821 5950558 Gastrointestinal disorder
595055821 5950558 Gastrooesophageal reflux disease
595055821 5950558 Generalised anxiety disorder
595055821 5950558 Hepatic steatosis
595055821 5950558 Inflammatory bowel disease
595055821 5950558 Insomnia
595055821 5950558 Intestinal haemorrhage
595055821 5950558 Iron deficiency anaemia
595055821 5950558 Irritable bowel syndrome
595055821 5950558 Liver function test increased
595055821 5950558 Megacolon
595055821 5950558 Microcytic anaemia
595055821 5950558 Oesophageal ulcer
595055821 5950558 Pneumonia
595055821 5950558 Pseudopolyp
595055821 5950558 Supraventricular tachycardia
595055821 5950558 Thrombocytopenia
595055821 5950558 Ventricular extrasystoles
595055821 5950558 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
595055821 5950558 1 20010718 200112 0